Dianzhou Bi

727 total citations
14 papers, 602 citations indexed

About

Dianzhou Bi is a scholar working on Pharmaceutical Science, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dianzhou Bi has authored 14 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dianzhou Bi's work include Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Lipid Membrane Structure and Behavior (3 papers). Dianzhou Bi is often cited by papers focused on Advanced Drug Delivery Systems (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Lipid Membrane Structure and Behavior (3 papers). Dianzhou Bi collaborates with scholars based in China, Japan and United States. Dianzhou Bi's co-authors include Shirui Mao, Florian T. Unger, Xintao Shuai, Thomas Kissel, Kazuhiro Morimoto, Jian Wang, Yasuhiko Tabata, Jianming Chen, Huan Liu and Yoshiharu Deguchi and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Dianzhou Bi

13 papers receiving 564 citations

Peers

Dianzhou Bi
Dianzhou Bi
Citations per year, relative to Dianzhou Bi Dianzhou Bi (= 1×) peers Andreas Bernkop‐Schnürch

Countries citing papers authored by Dianzhou Bi

Since Specialization
Citations

This map shows the geographic impact of Dianzhou Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianzhou Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianzhou Bi more than expected).

Fields of papers citing papers by Dianzhou Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianzhou Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianzhou Bi. The network helps show where Dianzhou Bi may publish in the future.

Co-authorship network of co-authors of Dianzhou Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Dianzhou Bi. A scholar is included among the top collaborators of Dianzhou Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianzhou Bi. Dianzhou Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Shujun, et al.. (2006). Validation of an HPLC method for the simultaneous determination of DZ5 and its active metabolite in dog plasma and its pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis. 42(3). 379–383. 1 indexed citations
2.
Yang, Lixia, Weishen Yang, Dianzhou Bi, & Qinghui Zeng. (2006). A novel method to prepare highly encapsulated interferon-α-2b containing liposomes for intramuscular sustained release. European Journal of Pharmaceutics and Biopharmaceutics. 64(1). 9–15. 22 indexed citations
3.
Mao, Shirui, et al.. (2006). Pharmacodynamics and Potential Toxicity of Intranasally Administered Dipyrone. Biological and Pharmaceutical Bulletin. 29(7). 1355–1359. 9 indexed citations
4.
Deng, Yihui, et al.. (2005). Characterization and Body Distribution ofβ-Elemene Solid Lipid Nanoparticles (SLN). Drug Development and Industrial Pharmacy. 31(8). 769–778. 36 indexed citations
5.
Zheng, Hangsheng & Dianzhou Bi. (2005). [Preparation of ondansetron hydrochloride osmotic pump tablets and their in vitro drug release].. PubMed. 40(12). 1080–4. 1 indexed citations
6.
Mao, Shirui, Pu Wang, & Dianzhou Bi. (2005). Investigations on 5-fluorouracil solid lipid nanoparticles (SLN) prepared by hot homogenization.. PubMed. 60(4). 273–7. 8 indexed citations
7.
Bi, Dianzhou. (2004). Studies on the preparing technique of melatonin starch microspheres for intranasal administration. Shenyang Yaoke Daxue xuebao.
8.
Mao, Shirui, et al.. (2004). Dissolution Improvement of Cisapride by Solid Dispersion with HPMC. Journal of Chinese Pharmaceutical Sciences. 13(4). 254. 2 indexed citations
9.
Mao, Shirui, et al.. (2004). Intranasal administration of melatonin starch microspheres. International Journal of Pharmaceutics. 272(1-2). 37–43. 73 indexed citations
10.
Mao, Shirui, et al.. (2004). The depolymerization of chitosan: effects on physicochemical and biological properties. International Journal of Pharmaceutics. 281(1-2). 45–54. 308 indexed citations
11.
Wang, Jian, et al.. (2002). Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats. Journal of Pharmacy and Pharmacology. 54(2). 181–188. 43 indexed citations
12.
Wang, Jian, Yasuhiko Tabata, Dianzhou Bi, & Kazuhiro Morimoto. (2001). Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. Journal of Controlled Release. 73(2-3). 223–231. 68 indexed citations
13.
Bi, Dianzhou, et al.. (2001). Design and Evaluation of a Two-Layer Floating Tablet for Gastric Retention Using Cisapride as a Model Drug. Drug Development and Industrial Pharmacy. 27(5). 469–474. 30 indexed citations
14.
Gao, Xiaoli, et al.. (2000). Pharmacokinetics of harmine intravenous emulsion in rats and mice.. Yaoxue xuebao. 35(3). 224–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026